Amgen Inc (AMGN)
295.06
+1.14
(+0.39%)
USD |
NASDAQ |
Apr 15, 12:54
Amgen Research and Development Expense (TTM): 5.964B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences Inc | 8.337B |
| Johnson & Johnson | 17.23B |
| Regeneron Pharmaceuticals Inc | 5.132B |
| Viking Therapeutics Inc | 101.64M |
| Moderna Inc | 4.543B |